The global assisted reproductive technology market size was valued at $2,317.7 million in 2020, and is estimated to reach $12,272.5 million by 2030, growing at a CAGR of 19.3% from 2021 to 2030. Assisted reproductive technology such as in vitro fertilization (IVF), artificial insemination (AI-IUI), and frozen embryo replacement, are used in the fertility clinics and surgical centers for the treatment of infertility.
Growth of the global assisted reproductive technology market is majorly driven by an increase in prevalence of infertility rate; rise in funding from private & government organizations for infertility services; rise in awareness regarding infertility treatment and surrogacy ; and increase in technology in the assisted reproductive technology. According to World Health Organization (WHO), in 2020, approximately 186 million individual and 48 million couple are diagnosed with infertility. According to Centers for Disease Control and Prevention (CDC), approximately 6% to 12% of the U.S. women suffering from PCOS were also diagnosed with infertility disorder. Thus, increase in prevalence of PCOS, surge the risk for infertility and drive the growth of assisted reproductive technology market. For instance, in February 2021, TMRW Life Sciences, a life science technology company providing platform for tracking and monitoring, announced the launch of world’s first automated cryo specimen management solution for eggs and embryo, which are used in the IVF procedure. Thus, the technological advancement features the use of software and imaging system in order to check the growth of embryo on the monitors. Moreover, in 2018, LUMSA University, in Italy, announced the WoMoGeS (Women’s movement and gestational surrogacy) project, which aims to raise awareness on gestational surrogacy among the vulnerable women in developing countries. Furthermore, the presence of emerging key players in assisted reproductive technologies and rise in disposable income propel the growth of the market.
However, high cost of assisted reproductive technology (ART) procedure and risk associated with in vitro fertilization treatment are expected to restrict the market growth during the forecast period.
Assisted Reproductive Technology Market Segmentation
The assisted reproductive technology market is segmented on the basis of product, technology, end user, and region. By product, the market is categorized into instrument, accessory & disposable and reagent & media. The instrument segment is further classified into sperm separation system, cryosystem, incubator, imaging system, ovum aspiration pump, cabinet, micromanipulator, laser systems, and others. The reagent & media segment is further divided into cryopreservation media, semen processing media, ovum processing media, and embryo culture media.
By technology, it is divided into in vitro fertilization, artificial insemination, and others. By end user, the market is fragmented into fertility clinic, hospital, surgical center, and clinical research institute.
Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Segment review
Depending on product, the accessory & disposable segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of infertility, surge in demand for in vitro fertilization procedure such as retrieval of oocytes, analysis & screening of sperms, handling gametes, and others. However, the reagent & media segment is expected to witness considerable market growth during the forecast period, owing to increase in demand for frozen embryo transfer, rise in prevalence of infertility, and surge in number of IVF procedures.
By Product
Accessory & Disposable segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.
On the basis of technology, the in-vitro fertilization segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to decrease in fertility rate, surge in sedentary lifestyle, increase in trend of delayed pregnancy and low cost of IVF procedure. However, the artificial insemination segment is expected to witness considerable growth during the forecast period, owing to surge in the number of investments in digital infrastructure and rise in demand for software upgrade and installation.
By Technology
In Vitro-Fertilization (IVF) segment is projected as one of the most lucrative segment.
On the basis of end user, the fertility clinic segment dominated the market in 2020, and is expected to continue this trend during the forecast period, owing to increase in prevalence of fertility cases, the surge in sedentary lifestyle, and growth in number of fertility clinics. However, the surgical center segment is expected to witness considerable growth during the forecast period, owing to increase in number of infertility surgical procedure and surge in demand for in-vitro fertilization.
By End User
Fertility clinic segment is projected as one of the most lucrative segment.
Europe accounted for a major share in the assisted reproductive technology market in 2020, and is expected to maintain its dominance during the forecast period, due to increase in utilization of novel technology equipment service, rise in incidence of infertility cases, high disposable incomes, rise of funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility in the region. However, Asia-Pacific is expected to register highest CAGR of 21.3% from 2021 to 2030, owing to increase in incidence of infertility cases, rise in awareness about surrogacy, and increase in demand for assisted reproductive technology.
By Region
Europe was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.
Key players operating in the global assisted reproductive technology market include Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc.), Thermo Fisher Scientific, Inc., Vitrolife AB.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the assisted reproductive technology market, and the current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the assisted reproductive technology market.
Key Market Segments
By Product
- Instrument
- Sperm Separation System
- Cryosystem
- Incubator
- Imaging System
- Ovum Aspiration Pump
- Cabinet
- Micromanipulator
- Laser Systems
- Others
- Accessory & Disposable
- Reagents & Media
- Cryopreservation Media
- Semen Processing Media
- Ovum Processing Media
- Embryo Culture Media
By Technology
- In Vitro-Fertilization
- Artificial Insemination
- Others
By End User
- Fertility Clinic
- Hospital
- Surgical Center
- Clinical Research Institute
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Cook Medical Inc.
- Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.)
- Genea Biomedx
- Merck KGaA (EMD Serono, Inc.)
- Millendo Therapeutics, Inc.
- Oxford Gene Technology
- Progyny Inc.
- The Cooper Companies, Inc. (CooperSurgical, Inc.)
- Thermo Fisher Scientific, Inc.
- Vitrolife AB
Assisted Reproductive Technology Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Technology |
|
 By End User |
|
 By Region |
|
 Key Market Players | VITROLIFE AB, OXFORD GENE TECHNOLOGY IP LTD., PROGYNY INC., GENEA BIOMEDX, THERMO FISHER SCIENTIFIC, INC., .MERCK KGAA, INCEPTION SCIENCES, INC., FUJIFILM HOLDINGS CORPORATION, THE COOPER COMPANIES, INC., COOK GROUP |
Analyst Review
Growth of the assisted reproductive technology market is attributed to factors such as technological advancements in in-vitro fertilization (IVF) devices; rise in prevalence of polycystic ovarian syndrome (PCOD); increase in incidence of infertility cases, and surge in demand for the IVF procedure. The assisted reproductive technology market gains interest of biotechnology and pharmaceutical companies, owing to surge in demand for cryopreservation media, embryo culture media, ovum aspiration pump, sperm separation system, laser assisted hatching, which are used for the treatment of infertility. This leads to increase in adoption of various procedure for the treatment of infertility. Moreover, the market has gained high traction in assisted reproductive technology, such as artificial insemination, in-vitro fertilization, and frozen embryo replacement, in recent years as assisted reproductive technology procedures are used in treatment of infertility.
Further, Europe is expected to witness highest growth, in terms of revenue, owing to increase in utilization of novel technology equipment service, rise in incidence of infertility cases, high disposable incomes, rise of funds from government and private organization for in-vitro fertilization (IVF), and advancements in technology for infertility.
Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in incidence of infertility cases, rise in awareness about surrogacy, and increase in demand for assisted reproductive technology.
In addition, high cost associated with ART and risk after the IVF procedure are anticipated to restrain the market growth during the forecast period.
The total market value of assisted reproductive technology Market is $2,317.7 million in 2020.
The forecast period in the report is from 2021 to 2030
The market value of assisted reproductive technology Market in 2021 was $2,500.8 million
The base year for the report is 2020.
Yes, assisted reproductive technology companies are profiled in the report
The top companies that hold the market share in assisted reproductive technology market are Cook Medical Inc., Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.), Genea Biomedx, Merck KGaA (EMD Serono, Inc.), Millendo Therapeutics, Inc., Oxford Gene Technology, Progyny Inc., The Cooper Companies, Inc. (CooperSurgical, Inc. Thermo Fisher Scientific, Inc., Vitrolife AB.
No, there is no value chain analysis provided in the assisted reproductive technology Market report
The key trends in the assisted reproductive technology Market are alarming increase in the prevalence of polycystic ovary syndrome, rise in disposable income, surge in demand for in vitro-fertilization, advancement in the technology for novel ART, and a rise in awareness about IVF and surrogacy.
Loading Table Of Content...
